Wegovy 1mg: understanding this dose and the decision it represents

Where 1mg of Wegovy sits in the schedule, and why it matters

The licensed titration for Wegovy runs in roughly four-weekly steps: 0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg. The full Wegovy dose schedule is designed around tolerability, not speed. Each step gives your body time to adjust to semaglutide's effects on gastric emptying before the dose increases again. Arriving at 1mg means you have already spent at least eight weeks on the medicine, and you are roughly halfway through the titration ladder.

That positioning matters for managing expectations. At 1mg, many people are starting to notice a meaningful reduction in appetite, but the headline trial results (around 15% average weight loss from the STEP 1 study published in the New England Journal of Medicine) were recorded at the 2.4mg maintenance dose, sustained over 68 weeks. The 1mg step is part of getting there safely, not the destination. If weight loss feels slow at this point, that is entirely normal; the dose is still building.

If you are curious about whether a modest loss at 1mg counts as meaningful progress, this question gets its own thorough answer here. The short version is that 1mg is neither a large nor a small dose in absolute terms, it is the right dose for where you are in the schedule.

What side effects tend to look like at this stage of titration

For many people, the step up to 1mg produces a noticeable uptick in gastrointestinal symptoms. Nausea is the most commonly reported. Loose stools, constipation, indigestion, bloating and a reduced interest in food can all appear or intensify. This is not a sign that the medicine is doing something wrong, it reflects semaglutide's mechanism slowing gastric emptying more strongly than the body has encountered before.

The NHS medicine page for semaglutide lists these common effects and explains that they tend to ease within a few days to a couple of weeks as the body settles. Eating smaller portions, avoiding fatty or heavily spiced food, and staying well hydrated all help during this window. If symptoms are severe or persistent, your prescriber may recommend pausing at 1mg for a further four weeks before moving to 1.7mg, the schedule can be slowed.

Rare but serious symptoms require prompt medical attention: severe, persistent stomach pain that spreads to the back (a possible sign of pancreatitis), signs of a serious allergic reaction, or symptoms of dehydration following prolonged vomiting or diarrhoea. These are not common, but they are the ones not to dismiss. Suspected side effects can be reported to the MHRA via the Yellow Card scheme.

The real decision: move up to 1.7mg, or hold?

After four weeks at 1mg, the prescribed next step is to progress to 1.7mg. But the question of whether to move up or hold is one that sits firmly with your prescriber, not with the titration schedule printed on a leaflet. Two things typically inform that call: how well you tolerated 1mg, and whether any clinical reason to pause has appeared.

If side effects at 1mg were significant and are still present after four weeks, staying put for another month is a reasonable and supported option. The move from 1mg to 1.7mg is the step many people find carries the biggest adjustment, partly because it is the largest proportional increase on the schedule. Rushing it when tolerance is still fragile is not, clinically, worth it.

Weight loss at 1mg also does not determine the decision. Some people see a good early response; others see very little until the maintenance dose is reached. Neither outcome changes the clinical logic of the titration. What matters is that each step is safe and that the prescription is actively reviewed before the next dose. At nume, every repeat is assessed by a real prescriber before it is issued, that review is not automated, and it covers this kind of decision directly.

For context on what the treatment costs as a whole, the Wegovy pricing page sets out what is included in a private prescription. Suitability and clinical fit are always confirmed at consultation.

What the pen itself looks like at 1mg, and one practical note

The Wegovy 1mg dose comes in a pre-filled injection pen. Understanding the 1mg Wegovy pen (how the dose is dialled, what the click mechanism does, and how to store it) is worth a moment of your time before you use it, especially if this is your first encounter with an injection pen. The pen is refrigerated between uses, and should be brought to room temperature briefly before each injection. For the exact storage window and injection instructions, the Patient Information Leaflet in your pack is the definitive reference; your prescriber or a pharmacist can also walk through it with you.

If you are weighing up whether semaglutide is the right treatment for your situation, the main Wegovy page covers the full picture, including who is eligible, how it compares to other licensed options, and what the treatment journey looks like from the first dose. Alternatively, if you are ready to find out whether treatment is right for you, a free consultation with our clinical team is the first step.